Related Experiment Video
Updated: Apr 20, 2026

09:03
Transpupillary Two-Photon In Vivo Imaging of the Mouse Retina
Published on: February 13, 2021
5.4K
Imaging retinal ganglion cells: enabling experimental technology for clinical application
Corey A Smith1, Balwantray C Chauhan2
1Retina and Optic Nerve Research Laboratory, Dalhousie University, 5850 College Street, PO Box 15000, Halifax, Nova Scotia B3H 4R2, Canada; Department of Physiology and Biophysics, Dalhousie University, 5850 College Street, PO Box 15000, Halifax, Nova Scotia B3H 4R2, Canada.
Progress in Retinal and Eye Research
|December 3, 2014
Summary
Advanced ophthalmic imaging can now visualize individual retinal ganglion cells (RGCs) in vivo. This breakthrough aids in monitoring RGC loss for glaucoma and optic neuropathies.
Area of Science:
- Ophthalmology
- Neuroscience
- Medical Imaging
Background:
- Clinical ophthalmic imaging has advanced patient care.
- Differentiating retinal neurons like retinal ganglion cells (RGCs) is crucial for diagnosing and monitoring glaucoma and optic neuropathies.
- Current imaging methods lack the single-cell resolution needed for advanced diagnostics.
Purpose of the Study:
- To review the importance and clinical relevance of non-invasive RGC imaging.
- To present experimental data on in vivo RGC labeling and monitoring.
- To discuss challenges and potential of translating RGC tracking to clinical applications.
Main Methods:
- Review of existing literature on RGC imaging techniques.
- In vivo intravitreal injection of a neuronal tracer in wild-type mice to label RGCs.
- Monitoring of labeled RGCs using confocal scanning laser ophthalmoscopy for up to 100 days.
Main Results:
- Demonstrated efficient and consistent RGC labeling via intravitreal injection.
- Successfully monitored labeled RGCs in vivo over an extended period.
- Discussed the critical aspect of cell specificity in RGC labeling.
Conclusions:
- In vivo RGC tracking shows promise for clinical applications in ophthalmology.
- This experimental approach is vital for developing methods to monitor RGC loss in diseases like glaucoma.
- Further research is needed to overcome challenges in translating these findings for clinical use.

